chloroquine has been researched along with Communicable Diseases in 9 studies
Chloroquine: The prototypical antimalarial agent with a mechanism that is not well understood. It has also been used to treat rheumatoid arthritis, systemic lupus erythematosus, and in the systemic therapy of amebic liver abscesses.
chloroquine : An aminoquinoline that is quinoline which is substituted at position 4 by a [5-(diethylamino)pentan-2-yl]amino group at at position 7 by chlorine. It is used for the treatment of malaria, hepatic amoebiasis, lupus erythematosus, light-sensitive skin eruptions, and rheumatoid arthritis.
Communicable Diseases: An illness caused by an infectious agent or its toxins that occurs through the direct or indirect transmission of the infectious agent or its products from an infected individual or via an animal, vector or the inanimate environment to a susceptible animal or human host.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Chloroquine and hydroxychloroquine, with an original indication to prevent or cure malaria, have been successfully used to treat several infectious (HIV, Q fever, Whipple's disease, fungal infections), rheumatological (systemic lupus erythematosus, antiphospholipid antibody syndrome, rheumatoid arthritis, Sjögren's syndrome), and other immunological diseases." | 4.98 | Current and Future Use of Chloroquine and Hydroxychloroquine in Infectious, Immune, Neoplastic, and Neurological Diseases: A Mini-Review. ( Koudriavtseva, T; Plantone, D, 2018) |
| " Additional liabilities of these medications include pharmacokinetic profiles that require extended dosing to achieve therapeutic tissue concentrations." | 2.66 | Nanomedicine Reformulation of Chloroquine and Hydroxychloroquine. ( Crist, RM; Stern, ST; Stevens, DM, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (77.78) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (11.11) | 24.3611 |
| 2020's | 1 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Stevens, DM | 1 |
| Crist, RM | 1 |
| Stern, ST | 1 |
| Plantone, D | 1 |
| Koudriavtseva, T | 1 |
| WERNER, R | 1 |
| HAUSS, WH | 1 |
| JUNGE-HUELSING, G | 1 |
| KRIKUNOV, VP | 1 |
| REICH, C | 1 |
| BAUMANN, A | 1 |
| SPENCE, HY | 1 |
| CASHMAN, JW | 1 |
| GALLAGHER, JA | 1 |
| STONE, CT | 1 |
| MILLER, MJ | 1 |
| MARCUS, DM | 1 |
| CAMERON, DG | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Proflaxis for Healthcare Professionals Using Hydroxychloroquine Plus Vitamin Combining Vitamins C, D and Zinc During COVID-19 Pandemia: An Observational Study[NCT04326725] | 80 participants (Anticipated) | Observational | 2020-03-20 | Active, not recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 reviews available for chloroquine and Communicable Diseases
| Article | Year |
|---|---|
Nanomedicine Reformulation of Chloroquine and Hydroxychloroquine.
Topics: Animals; Antimalarials; Chloroquine; Communicable Diseases; Drug Compounding; Humans; Hydroxychloroq | 2020 |
Current and Future Use of Chloroquine and Hydroxychloroquine in Infectious, Immune, Neoplastic, and Neurological Diseases: A Mini-Review.
Topics: Anti-Infective Agents; Anti-Inflammatory Agents; Antimalarials; Antineoplastic Agents; Antirheumatic | 2018 |
7 other studies available for chloroquine and Communicable Diseases
| Article | Year |
|---|---|
[Resochin prophylaxis in voyages in malaria-infested regions].
Topics: Chloroquine; Communicable Diseases; Humans; Malaria; Parasitic Diseases | 1956 |
[Changes in connective tissue metabolism by toxic, infectious and allergic influences].
Topics: Aging; Chloroquine; Chondroitin; Communicable Diseases; Connective Tissue; Cortisone; Humans; Thyrox | 1961 |
[Treatment of infectious non-specific (rheumatoid) polyarthritis with Resochin].
Topics: Arthritis; Arthritis, Rheumatoid; Chloroquine; Communicable Diseases | 1961 |
Estivo-autumnal malaria in New York City. Diagnostic difficulties.
Topics: Chloroquine; Communicable Diseases; Hepatitis A; Humans; Malaria; New York City; Penicillins; Pneumo | 1963 |
PEACE CORPS HEALTH EXPERIENCES ABROAD.
Topics: Amebiasis; Chloroquine; Communicable Diseases; Dermatology; Dysentery; Dysentery, Amebic; Gastroente | 1963 |
SAFETY OF CHLOROQUINE IN PREGNANCY.
Topics: Arthritis; Arthritis, Rheumatoid; Chloroquine; Communicable Diseases; Drug Therapy; Female; Pregnanc | 1965 |
LATENT INFECTIONS WITH PLASMODIUM OVALE MALARIA.
Topics: Africa, Western; Aminoquinolines; Canada; Chloroquine; Communicable Diseases; Diagnosis; Drug Therap | 1965 |